Tutto DSpace

Sfoglia per Soggetto "Heparin, Low-Molecular-Weight"

Items 1-8 di 8

    • Administration of low-molecular-weight heparin in patients with two or more unsuccessful IVF/ICSI cycles: a multicenter cohort study 

      Siristatidis C., Dafopoulos K., Salamalekis G., Galazios G., Christoforidis N., Moustakarias T., Koutlaki N., Bouschanetzis C., Loutradis D., Drakakis P. (2018)
      To compare the effects of the administration of low-molecular-weight heparin (LMWH) in subfertile patients with two or more unsuccessful IVF/ICSI cycles. In this six-center two-arm retrospective cohort study, the study ...

    • Administration of prednisolone and low molecular weight heparin in patients with repeated implantation failures: a cohort study 

      Siristatidis C., Dafopoulos K., El-Khayat W., Salamalekis G., Anifandis G., Vrantza T., Elsadek M., Papantoniou N. (2018)
      Conflicting results exist for low molecular weight heparin (LMWH) and prednisolone when tested as separate adjuncts for the improvement of the clinical outcomes in patients with repeated implantation failures (RIF) undergoing ...

    • Anticoagulation after Stroke in Patients with Atrial Fibrillation: To Bridge or Not with Low-Molecular-Weight Heparin? 

      Altavilla R., Caso V., Bandini F., Agnelli G., Tsivgoulis G., Yaghi S., Furie K.L., Tadi P., Becattini C., Zedde M., Abdul-Rahim A.H., Lees K.R., Alberti A., Venti M., Acciarresi M., D'Amore C., Giulia Mosconi M., Anna Cimini L., Fusaro J., Bovi P., Carletti M., Rigatelli A., Cappellari M., Putaala J., Tomppo L., Tatlisumak T., Marcheselli S., Pezzini A., Poli L., Padovani A., Masotti L., Vannucchi V., Sohn S.-I., Lorenzini G., Tassi R., Guideri F., Acampa M., Martini G., Ntaios G., Athanasakis G., Makaritsis K., Karagkiozi E., Vadikolias K., Liantinioti C., Chondrogianni M., Mumoli N., Consoli D., Galati F., Sacco S., Carolei A., Tiseo C., Corea F., Ageno W., Bellesini M., Silvestrelli G., Ciccone A., Lanari A., Scoditti U., Denti L., Mancuso M., MacCarrone M., Ulivi L., Orlandi G., Giannini N., Gialdini G., Tassinari T., De Lodovici M.L., Bono G., Rueckert C., Baldi A., D'Anna S., Toni D., Letteri F., Giuntini M., Lotti E.M., Flomin Y., Pieroni A., Kargiotis O., Karapanayiotides T., Monaco S., Baronello M.M., Csiba L., Szabó L., Chiti A., Giorli E., Del Sette M., Imberti D., Zabzuni D., Doronin B., Volodina V., Michel P., Vanacker P., Barlinn K., Pallesen L.-P., Barlinn J., Deleu D., Melikyan G., Ibrahim F., Akhtar N., Gourbali V., Paciaroni M. (2019)
      Background and Purpose-Bridging therapy with low-molecular-weight heparin reportedly leads to a worse outcome for acute cardioembolic stroke patients because of a higher incidence of intracerebral bleeding. However, this ...

    • COVID-19 associated pulmonary embolism with D-dimer values within the referent range: A case report and review of the literature 

      Javorac J., Živanovic D., Stojkov S., Milicic J.D., Fradelos E., Savic N. (2021)
      OBJECTIVE: COVID-19 is associated with an increased incidence of pulmonary embolism (PE). Elevated D-dimer levels are linked to an increased risk of PE and poor clinical outcome. We reported a case of PE in a COVID-19 ...

    • Low-molecular-weight heparin for prevention of thrombosis: Inverted role 

      Dailiana, Z. H.; Malizos, K. N.; Varitimidis, S.; Hantes, M.; Basdekis, G.; Rigopoulos, N. (2007)
      BACKGROUND: Heparin induced thrombosis (HIT) after low-molecular-weight (LMWH) administration for thrombosis prevention is a limb and life threatening condition. METHODS: Two previously healthy individuals, with nonviable ...

    • New prophylaxis strategies to reduce the risk of thromboembolism in cancer 

      Papadopoulos V., Tsapakidis K., Markou A., Kokkalis A., Aidarinis C., Kotsakis A. (2021)
      Introduction: Patients with cancer are at risk of thrombotic events, mainly deep vein thrombosis and/or pulmonary embolism. The thrombosis risk is generally 4–6 times higher than in a healthy population and depends on ...

    • The role of direct oral anticoagulants in cancer-associated thrombosis according to the current literature 

      Nana P., Dakis K., Peroulis M., Rousas N., Spanos K., Kouvelos G., Arnaoutoglou E., Matsagkas M. (2021)
      Venous thromboembolism (VTE) is a common complication among patients suffering from malignancies, leading to an increased mortality rate. Novel randomized trials have added valuable information regarding cancer-associated ...

    • Treatment of superficial vein thrombosis with intermediate dose of tinzaparin: A real word cohort study – The SeVEN EXTension study 

      Karathanos C., Chatzis D., Latzios P., Papakostas I., Goumas K., Giannoukas A.D., on behalf of the SeVEN EXT Collaborators (2021)
      Background: To assess the treatment of superficial vein thrombosis (SVT) with intermediate dose of tinzaparin in a setting of real world practice. Methods: Prospective observational study of consecutive patients treated ...